• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛癌中REST共抑制因子的综合分析。

Comprehensive analysis of REST corepressors (s) in pan-cancer.

作者信息

Zheng Rong, Pan Yingying, Liu Xinhui, Liu Feiye, Li Aimin, Zheng Dayong, Luo Yue

机构信息

Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.

Cancer Center, TCM-Integrated Hospital of Southern Medical University, Guangzhou, China.

出版信息

Front Cell Dev Biol. 2023 Jun 5;11:1162344. doi: 10.3389/fcell.2023.1162344. eCollection 2023.

DOI:10.3389/fcell.2023.1162344
PMID:37342230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10277624/
Abstract

REST corepressors (s) are the core component of the LSD1/CoREST/HDACs transcriptional repressor complex, which have been revealed differently expressed in various cancers, but the therapeutic and prognostic mechanisms in cancer are still poorly understood. In this study, we analyzed expression, prognostic value, molecular subtypes, genetic alteration, immunotherapy response and drug sensitivity of s in pan-cancer. Clinical correlation, stemness index, immune infiltration and regulatory networks of s in hepatocellular carcinoma (HCC) were detected through TCGA and GSCA database. experiments were conducted to explore the role of RCOR1 in HCC cells. The expression of s varied among different cancers, and have prognostic values in several cancers. Cancer subtypes were categorized according to the expression of s with clinical information. s were significantly correlated with immunotherapy response, MSI, drug sensitivity and genetic alteration in pan-cancer. In HCC, s were considered as potential predictor of stemness and also had association with immune infiltration. The ceRNA-TF-kinase regulatory networks of s were constructed. Besides, RCOR1 acts as an oncogene in HCC and promotes the proliferation of HCC cells by inhibiting cell cycle arrest and cell apoptosis. Taken together, our study revealed the potential molecular mechanisms of s in pan-cancer, offering a benchmark for disease-related research.

摘要

REST共抑制因子是LSD1/CoREST/HDACs转录抑制复合物的核心组成部分,已发现在各种癌症中表达不同,但癌症中的治疗和预后机制仍知之甚少。在本研究中,我们分析了泛癌中REST共抑制因子的表达、预后价值、分子亚型、基因改变、免疫治疗反应和药物敏感性。通过TCGA和GSCA数据库检测了肝细胞癌(HCC)中REST共抑制因子的临床相关性、干性指数、免疫浸润和调控网络。进行实验以探索RCOR1在肝癌细胞中的作用。REST共抑制因子的表达在不同癌症中有所不同,并且在几种癌症中具有预后价值。根据REST共抑制因子的表达和临床信息对癌症亚型进行分类。REST共抑制因子在泛癌中与免疫治疗反应、微卫星不稳定性(MSI)、药物敏感性和基因改变显著相关。在肝癌中,REST共抑制因子被认为是干性的潜在预测指标,并且还与免疫浸润有关。构建了REST共抑制因子的ceRNA-转录因子-激酶调控网络。此外,RCOR1在肝癌中作为癌基因发挥作用,通过抑制细胞周期停滞和细胞凋亡促进肝癌细胞的增殖。综上所述,我们的研究揭示了泛癌中REST共抑制因子的潜在分子机制,为疾病相关研究提供了一个基准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/b460ca9d7adf/fcell-11-1162344-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/acc89e8a866b/fcell-11-1162344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/6dbbd42b9779/fcell-11-1162344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/5c9ef23ca72c/fcell-11-1162344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/2289b9dfc14d/fcell-11-1162344-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/b33fb9e490d5/fcell-11-1162344-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/ca216553a94c/fcell-11-1162344-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/8cbaa8e47706/fcell-11-1162344-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/7dd74a6d39bb/fcell-11-1162344-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/7667e97292cf/fcell-11-1162344-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/b460ca9d7adf/fcell-11-1162344-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/acc89e8a866b/fcell-11-1162344-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/6dbbd42b9779/fcell-11-1162344-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/5c9ef23ca72c/fcell-11-1162344-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/2289b9dfc14d/fcell-11-1162344-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/b33fb9e490d5/fcell-11-1162344-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/ca216553a94c/fcell-11-1162344-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/8cbaa8e47706/fcell-11-1162344-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/7dd74a6d39bb/fcell-11-1162344-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/7667e97292cf/fcell-11-1162344-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/10277624/b460ca9d7adf/fcell-11-1162344-g010.jpg

相似文献

1
Comprehensive analysis of REST corepressors (s) in pan-cancer.泛癌中REST共抑制因子的综合分析。
Front Cell Dev Biol. 2023 Jun 5;11:1162344. doi: 10.3389/fcell.2023.1162344. eCollection 2023.
2
Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.全面泛癌基因组分析揭示 PHF19 作为一种致癌标志物与肝细胞癌的免疫浸润和预后相关。
Front Immunol. 2022 Jan 5;12:781087. doi: 10.3389/fimmu.2021.781087. eCollection 2021.
3
A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.泛癌种中肌动蛋白相关蛋白 2/3 复合物亚基 5 的全面预后和免疫分析及在肝细胞癌中的鉴定。
Front Immunol. 2022 Sep 6;13:944898. doi: 10.3389/fimmu.2022.944898. eCollection 2022.
4
Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma.MELK相关ceRNA网络的综合分析揭示了一种预测肝细胞癌预后不良和免疫治疗疗效的潜在生物标志物。
Front Cell Dev Biol. 2022 May 27;10:824938. doi: 10.3389/fcell.2022.824938. eCollection 2022.
5
ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.ARPC2:一种促进肝癌细胞增殖和侵袭的泛癌预后及免疫生物标志物
Front Cell Dev Biol. 2022 Jun 6;10:896080. doi: 10.3389/fcell.2022.896080. eCollection 2022.
6
Pan-Cancer Profiling and Digital Pathology Analysis Reveal Negative Prognostic Biomarker ZPR1 Associated with Immune Infiltration and Treatment Response in Hepatocellular Carcinoma.泛癌分析与数字病理学分析揭示负性预后生物标志物ZPR1与肝细胞癌的免疫浸润及治疗反应相关
J Hepatocell Carcinoma. 2023 Aug 9;10:1309-1325. doi: 10.2147/JHC.S415224. eCollection 2023.
7
[Pan-cancer analysis of the expression pattern of long non-coding RNA MIR22HG].长链非编码RNA MIR22HG表达模式的泛癌分析
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Apr 20;42(4):473-485. doi: 10.12122/j.issn.1673-4254.2022.04.03.
8
Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.RAB22A 在肝细胞癌中的预后价值和免疫作用特征。
Front Immunol. 2023 Mar 3;14:1086342. doi: 10.3389/fimmu.2023.1086342. eCollection 2023.
9
Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma.从泛癌到肝细胞癌对肿瘤促进作用及免疫浸润相关性MAZ的综合分析。
Int Immunopharmacol. 2023 Feb;115:109660. doi: 10.1016/j.intimp.2022.109660. Epub 2023 Jan 7.
10
a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation.一种参与肝细胞癌分子调控机制的泛癌预后标志物:基于数据挖掘、生物信息学和体外验证的综合研究
Onco Targets Ther. 2019 Dec 31;12:11637-11650. doi: 10.2147/OTT.S231750. eCollection 2019.

引用本文的文献

1
REST corepressor 2 contributes to the cell proliferation of endometrial cancer.REST共抑制因子2促进子宫内膜癌的细胞增殖。
Front Oncol. 2025 Aug 27;15:1539263. doi: 10.3389/fonc.2025.1539263. eCollection 2025.
2
RCOR1 is targeted by miR-23b-3p to modulate growth, colony formation, migration, and invasion of prostate cancer cells.RCOR1是miR-23b-3p的作用靶点,可调节前列腺癌细胞的生长、集落形成、迁移和侵袭。
Int J Clin Exp Pathol. 2024 Feb 15;17(2):29-38. doi: 10.62347/MNSQ2960. eCollection 2024.

本文引用的文献

1
GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels.GSCA:一个用于在基因组、药物基因组学和免疫基因组学水平进行基因集癌症分析的综合平台。
Brief Bioinform. 2023 Jan 19;24(1). doi: 10.1093/bib/bbac558.
2
Endocrine resistance and breast cancer plasticity are controlled by CoREST.CoREST 控制内分泌抵抗和乳腺癌可塑性。
Nat Struct Mol Biol. 2022 Nov;29(11):1122-1135. doi: 10.1038/s41594-022-00856-x. Epub 2022 Nov 7.
3
WITHDRAWN: In Vitro and In Vivo Anti-lung Cancer Activity of Emodin: An RNAseq Transcriptome Analysis.
撤回:大黄素的体外和体内抗肺癌活性:一项RNA测序转录组分析
Curr Med Chem. 2025 Jan 1. doi: 10.2174/0929867329666220921120314.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Development and Clinical Validation of a Novel 4-Gene Prognostic Signature Predicting Survival in Colorectal Cancer.一种预测结直肠癌生存的新型4基因预后特征的开发与临床验证
Front Oncol. 2020 May 20;10:595. doi: 10.3389/fonc.2020.00595. eCollection 2020.
6
RCOR1 directly binds to MED28 and weakens its inducing effect on cancer stem cell-like activity of oral cavity squamous cell carcinoma cells.RCOR1 直接与 MED28 结合,并削弱其对口腔鳞状细胞癌细胞癌干细胞样活性的诱导作用。
J Oral Pathol Med. 2020 Sep;49(8):741-750. doi: 10.1111/jop.13022. Epub 2020 May 14.
7
More than a Corepressor: The Role of CoREST Proteins in Neurodevelopment.不仅仅是核心抑制物:CoREST 蛋白在神经发育中的作用。
eNeuro. 2020 Mar 10;7(2). doi: 10.1523/ENEURO.0337-19.2020. Print 2020 Mar/Apr.
8
Inhibiting the coregulator CoREST impairs Foxp3+ Treg function and promotes antitumor immunity.抑制共调节因子 CoREST 会损害 Foxp3+Treg 功能并促进抗肿瘤免疫。
J Clin Invest. 2020 Apr 1;130(4):1830-1842. doi: 10.1172/JCI131375.
9
DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.高级广基锯齿状腺瘤发生异型增生前的 DNA 甲基化改变。
Clin Epigenetics. 2019 Jun 14;11(1):90. doi: 10.1186/s13148-019-0691-4.
10
SnapShot: TCGA-Analyzed Tumors.Snapshot:TCGA 分析的肿瘤。
Cell. 2018 Apr 5;173(2):530. doi: 10.1016/j.cell.2018.03.059.